Clinical trial Recruiting at 1 site Observational

Registry for patients with Krabbe disease

Official title: The Institute for Myelin and Glia Exploration's Clinical Database of Patients With Krabbe Disease, A World-Wide Registry

Run by State University of New York at Buffalo · NCT02993796 · Data updated 2026-11-12

This study is creating a database for people with Krabbe disease to see how symptoms, genetic factors, and test results can help understand the disease better and improve treatment.

Quick facts

Study typeObservational
SexAll
Enrollment60 (estimated)
SponsorState University of New York at Buffalo
Academic / other
Locations1 site (Buffalo, New York)
StatusRecruiting
StartedSeptember 2014
Main results expectedMarch 2027
Study endsMarch 2027
Registry record updatedOctober 28, 2026
Trial IDNCT02993796 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals diagnosed with Krabbe disease, those at risk for the disease, and family members of affected individuals.

Probably not a fit

Patients who are not diagnosed with or at risk for Krabbe disease will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to create a clinical database for individuals diagnosed with Krabbe disease to identify symptoms that indicate the onset of the disease across its various phenotypes. It will explore the relationship between GALC enzyme activity levels, specific genetic mutations, and the clinical course of the disease. Additionally, the study seeks to determine which neurodiagnostic tests can predict the onset and severity of Krabbe disease. By enhancing the understanding of the disease's phenotypic variations, the registry aims to improve diagnostic accuracy and treatment timing.

Why it matters

Potential benefit: If successful, this registry could lead to better diagnosis and management of Krabbe disease, ultimately improving patient outcomes.

How similar studies have gone: While this approach is observational and aims to gather data, similar registries for rare diseases have shown success in improving understanding and management of those conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Anyone diagnosed with Krabbe disease
* Anyone at-risk for Krabbe disease
* Family members of someone diagnosed with, or at-risk for, Krabbe disease.

Exclusion Criteria:

* Anyone who is not diagnosed with, or at-risk for, Krabbe disease
* Anyone who is not a family member of someone diagnosed with, or at-risk for, Krabbe disease

Where it's running

  • State University of New York at Buffalo
    Buffalo, New York, United States
    Recruiting

Study contacts

  • Principal investigator: Thomas J. Langan, MD — Clinical Director, Clinical Research, Institute for Myelin and Glial Exploration
  • Study coordinator: Thomas J. Langan, MD
  • Email: tjlangan@buffalo.edu
  • Phone: 716-888-4732

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.